QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CRON

QT56Cronos Group Inc.
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·Canada
Latest market price
2.71
+0.04+1.50%
OverviewShort InterestFilings
CRONQT56Cronos Group Inc.·NASDAQ
OverviewShort InterestFilings
2.71+1.50%
TA
Loading chart...
Screen all →
TAK+1.36%$15.63HLN+1.01%$8.96TEVA-3.32%$31.48VTRS-2.29%$15.37ELAN+3.55%$24.22RDY+1.06%$13.29RGC-18.96%$12.01LNTH+0.65%$103.86
Snapshot
Index-P/E-EPS (ttm)
0.00
Insider Own-
Shs Outstand-
Perf Week-1.45%
Market Cap994.24MForward P/E25.41EPS next Y0.11Insider Trans-Shs Float-Perf Month3.83%
Enterprise Value173.12MPEG3.90EPS next Q0.01Inst Own-Short Float-Perf Quarter10.16%
Income-1988481.00P/S6.23EPS this Y-Inst Trans-Short Ratio-Perf Half Y-14.24%
Sales159.47MP/B0.94EPS next Y21.91%ROA-0.18%Short Interest-Perf YTD3.04%
Book/sh-P/C25.96EPS next 5Y18.06%ROE-0.19%52W High3.43 -20.99%Perf Year41.88%
Cash/sh-P/FCF37.59EPS past 3/5Y-ROIC0.78%52W Low1.84 47.28%Perf 3Y-
Dividend Est.-EV/EBITDA3.62Sales past 3/5Y19.64% 25.96%Gross Margin42.19%Volatility2.27% 2.27%Perf 5Y-
Dividend TTM-EV/Sales1.09EPS Y/Y TTM-122.45%Oper. Margin-7.77%ATR (14)0.10Perf 10Y-
Dividend Ex-Date-Quick Ratio20.73Sales Y/Y TTM73.73%Profit Margin-1.29%RSI (14)50.43Recom3.00
Dividend Gr. 3/5Y-Current Ratio21.87EPS Q/Q-SMA20-0.99%Beta0.94Target Price2.30
Payout0.00%Debt/Eq0.00Sales Q/Q40.63%SMA500.79%Rel Volume0.73Prev Close2.67
Employees459LT Debt/Eq0.00EarningsAug 06SMA2003.49%Avg Volume1.66MPrice2.71
IPO DateFeb 27, 2018Option/ShortNo / YesEPS/Sales Surpr.0.00% 7.14%Net Debt/EBITDA-17.17Volume1,213,826Change1.50%
Analyst Ratings
DateActionAnalystRatingTarget
Jan-14-26ReiteratedBernsteinPerform$2.30
Aug-09-24ReiteratedBank of America Securities$2.30
Sep-30-22ReiteratedBarclaysEqual Weight$3.50
May-11-22ReiteratedCanaccord GenuitySell$4.50
Mar-22-22UpgradeBarclaysUnderweight → Equal Weight
Jan-27-22UpgradeJefferiesUnderperform → Hold
Apr-14-20DowngradePiper SandlerOverweight → Neutral
Mar-31-20DowngradeCanaccord GenuityHold → Sell
Aug-09-19UpgradeCanaccord GenuitySell → Hold
Jun-05-19UpgradeB of A SecuritiesUnderperform → Buy
Latest News
Jun-18-26
Jun-18-2612:35PM
Cannabis Stocks Split into Two Camps: Profitable Operators vs. High-Growth SpeculationChartMill
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue205149118
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1388792
Gross Profit676225
Selling, General and Administrative Excl. Other656477
Research and Development444
Other Operating Expense-11221
Operating Income0-18-77
Interest Expense000
Unusual Expense
———
Non-Operating Income (Expense)140-17
Net Income Before Taxes-6-1737
Income Taxes-12-14-3
Consolidated Net Income-2-1041
Net Income From Continuing Operations5-340
Net Income-2-1041
EPS (Recurring)0.00-0.030.11
EPS (Basic, Before Extraordinaries)0.00-0.030.11
EPS (Diluted)0.00-0.030.11
EBITDA-12-3-50
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio5.096.80—
Gross Margin32.6841.6121.19
Operating Margin0.00-12.08-65.25
Net Margin-0.98-6.7134.75
Shares Outstanding385385382
Market Capitalization1,0431,013—
Operating Lease Expense
———
Insider Trading Volume
$2.85$2.67$2.50$2.32$2.14● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Doucet Terrence Gregory JosephSee RemarksMay 12 '26Option Exercise0.0021,1940173,811May 14 12:00 AM
Buggy ShannonSee RemarksMay 12 '26Option Exercise0.0041,2440187,501May 14 12:00 AM
Kenost Jared MatthewSee RemarksMay 12 '26Option Exercise0.0018,824053,942May 14 12:00 AM
Wagner AdamSee remarksMay 12 '26Option Exercise0.0020,7340155,269May 14 12:00 AM
Weigensberg AryeSee RemarksMay 10 '26Option Exercise0.006,2360211,555May 12 12:00 AM
Wagner AdamSee remarksMay 10 '26Option Exercise0.0040,9400176,043May 12 12:00 AM
Kenost Jared MatthewSee RemarksMay 10 '26Option Exercise0.0025,298039,141May 12 12:00 AM
Shlimak AnnaSee RemarksMar 19 '26Option Exercise0.0056,8580386,893Mar 20 12:00 AM
Weigensberg AryeSee RemarksMar 15 '26Option Exercise0.0048,4720208,437Mar 17 12:00 AM
GORENSTEIN MICHAEL RYANSee remarks belowMar 15 '26Option Exercise0.00649,080013,340,723Mar 17 12:00 AM
Shlimak AnnaSee RemarksMar 15 '26Option Exercise0.0090,4520415,322Mar 17 12:00 AM
JACOBSON JEFFREY DAVIDChief Growth OfficerMar 15 '26Option Exercise0.00118,3820507,233Mar 17 12:00 AM
Buggy ShannonSee RemarksMar 15 '26Option Exercise0.0041,8760200,906Mar 17 12:00 AM
Doucet Terrence Gregory JosephSee RemarksMar 15 '26Option Exercise0.0047,7940184,408Mar 17 12:00 AM
Doucet Terrence Gregory JosephSee RemarksMar 12 '26Option Exercise0.0047,6180208,305Mar 16 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR